openPR Logo
Press release

Biodefense Market : Estimated to Experience a Hike in Growth by 2023

01-18-2018 03:11 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Biodefense Market : Estimated to Experience a Hike in Growth

The research report analyzes the global Biodefense Market on the basis of market forces, current market trends, and major geographies. The report is an in-depth analysis of industry growth drivers, challenges, and opportunities of the market for the forecast period. It includes an analysis of recent technological developments in the market.

The global biodefense market is displaying admirable growth due to the increasing importance for disease surveillance mission to combat bioterrorism. The outbreak of anthrax subsequent to September 11, 2001, attack has raised vigilance among government bodies for improving public health preparedness and to improve the response time in the event of a disaster. The funding for preparedness of bioterrorism has augmented the capabilities of Public Health Services to enhance its surveillance activities, resulting in effective monitoring of community health. The increasing focus of Public Health Services for the development of tests and procedures to identify biothreat agents is also driving the biodefense market. The recent Ebola outbreak and nuclear crisis in Japan are anticipated to have a positive impact on the growth of the biodefense market.

Request Brochure of The Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5369

The global biodefense market is divided into the regional segments of North America, Europe, Asia Pacific, and the Middle East and Latin America. North America is the largest market for biodefense due to enhanced lab capabilities and improved infrastructure for raising alarm for the threat to health. Europe is the second largest market for biodefense. Asia Pacific is expected to emerge as a significant market for biodefense due to the increasing adoption of precise analytical instruments and rapid advancement of the biotechnology industry. Other regions such as the Middle East and Latin America are anticipated to be significant regions for biodefense due to the expanding portfolio of leading biotechnology players in these regions.

Some of the leading companies operating in the global biodefense market are Alnylam Pharmaceuticals, Dynavax Technologies Inc., Emergent BioSolutions, SIGA Technologies, Acambis plc, Evogen Inc., Human Genome Sciences, and PharmAthene Inc.

Request Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=5369

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biodefense Market : Estimated to Experience a Hike in Growth by 2023 here

News-ID: 907572 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Biodefense

Biodefense Treatment Market 2025| Target U.S For Maximum Profitability in Biodef …
Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025. Get Sample of this
Incredible Growth of Biodefense Market 2027
The research report on Biodefense Market provides a comprehensive analysis of the market status and development trend, including types, applications, growth, opportunities, rising technology, competitive landscape and product offerings of key players. Biodefense Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. Some of the key players of Biodefense Market: Bavarian Nordic, 2. Alnylam Pharmaceuticals,
Biodefense Market Industry Trends, Estimation & Forecast, 2018-2025
Significant funding by the U.S. civilian and military organizations, such as Centers for Disease Control and Prevention (CDC), The United States Department of Health & Human Services (HHS), and The Department of Defense (DoD), is also boosting the market growth. Rising prevalence of infectious diseases, such as influenza, is estimated to be one of the key factors boosting the investments for biological threats. In U.S., the federal agency has allocated
Biodefense Market - Real Time Analysis
Biodefense has been advancing, particularly in the U.S., subsequent to the 2001 anthrax attack. The use of biological warfare can be traced back to 1346 A.D. when plaque afflicted human corpses were hurled over the besieged walls of Caffa. Presently, the use of biological warfare is banned following a United Nations convention signed in 1972. However, the absence of verification protocol has not been sufficient to prevent countries from developing
Biodefense Market share valued $17bn by 2024
According to research report “Biodefense Market Size By Product (Anthrax, Small Pox, Botulism, Radiation/ Nuclear), Industry Analysis Report, Regional Outlook (U.S., Canada, U.K, Germany, China, Japan, Mexico, Brazil, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Global Biodefense Market size contribution was $9.8 billion for 2015 with CAGR of 6.91% predicted to be registered for forecast timeline. Rising bioterrorism
Biodefense Market share valued $17bn by 2024
According to research report “Biodefense Market Size By Product (Anthrax, Small Pox, Botulism, Radiation/ Nuclear), Industry Analysis Report, Regional Outlook (U.S., Canada, U.K, Germany, China, Japan, Mexico, Brazil, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Global Biodefense Market size contribution was $9.8 billion for 2015 with CAGR of 6.91% predicted to be registered for forecast timeline. Rising bioterrorism